226 related articles for article (PubMed ID: 9241369)
21. Docetaxel in combination with fluorouracil for advanced solid tumors.
Burris HA
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):50-2. PubMed ID: 9364544
[TBL] [Abstract][Full Text] [Related]
22. Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer.
Herman LC; Chen L; Garnett A; Feldman LE; Smith B; Weichselbaum RR; Spiotto MT
Oral Oncol; 2014 Jan; 50(1):52-8. PubMed ID: 24055193
[TBL] [Abstract][Full Text] [Related]
23. Docetaxel (Taxotere) in combination chemotherapy and in association with thoracic radiotherapy for the treatment of non-small-cell lung cancer. Thoracic Oncology Program.
Ornstein DL; Nervi AM; Rigas JR
Ann Oncol; 1999; 10 Suppl 5():S35-40. PubMed ID: 10582137
[TBL] [Abstract][Full Text] [Related]
24. Gemcitabine: progress in the treatment of pancreatic cancer.
Heinemann V
Oncology; 2001; 60(1):8-18. PubMed ID: 11150902
[TBL] [Abstract][Full Text] [Related]
25. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
Grossi F; de Marinis F; Frontini L; Gridelli C
Tumori; 2008; 94(3):5-14. PubMed ID: 18705422
[No Abstract] [Full Text] [Related]
26. [The update on pancreatic cancer chemotherapy].
Brasiūniene B; Juozaityte E; Brasiūnas V; Inciūra A
Medicina (Kaunas); 2003; 39(10):1016-25. PubMed ID: 14578647
[TBL] [Abstract][Full Text] [Related]
27. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.
Haddad R; Tishler RB; Norris CM; Mahadevan A; Busse P; Wirth L; Goguen LA; Sullivan CA; Costello R; Case MA; Posner MR
Oncologist; 2003; 8(1):35-44. PubMed ID: 12604730
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel.
Edelman MJ; Clark JI; Chansky K; Albain K; Bhoopalam N; Weiss GR; Giguere JK; Kelly K; Crowley J; Gandara DR
Clin Cancer Res; 2004 Aug; 10(15):5022-6. PubMed ID: 15297403
[TBL] [Abstract][Full Text] [Related]
29. Present and future treatment of pancreatic cancer.
Heinemann V
Semin Oncol; 2002 Jun; 29(3 Suppl 9):23-31. PubMed ID: 12094335
[TBL] [Abstract][Full Text] [Related]
30. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
31. Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
Brockstein B
Curr Opin Oncol; 2000 May; 12(3):221-8. PubMed ID: 10841194
[TBL] [Abstract][Full Text] [Related]
32. Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials.
Heinemann V
Semin Oncol; 2002 Dec; 29(6 Suppl 20):9-16. PubMed ID: 12577228
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer.
Karasawa K; Shinoda H; Katsui K; Seki K; Kohno M; Hanyu N; Nasu S; Muramatsu H; Maebayashi K; Mitsuhashi N; Yoshihara T
Anticancer Res; 2002; 22(6B):3785-8. PubMed ID: 12552993
[TBL] [Abstract][Full Text] [Related]
34. Developmental chemotherapy and management of recurrent ovarian cancer.
Bookman MA
J Clin Oncol; 2003 May; 21(10 Suppl):149s-167s. PubMed ID: 17633784
[TBL] [Abstract][Full Text] [Related]
35. Rationale for non-platinum chemotherapy in advanced NSCLC.
Murren JR
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
[TBL] [Abstract][Full Text] [Related]
36. [Carboplatin].
Watanabe H
Nihon Rinsho; 2002 May; 60 Suppl 5():366-9. PubMed ID: 12101690
[No Abstract] [Full Text] [Related]
37. Phase Ib study of duligotuzumab (MEHD7945A) plus cisplatin/5-fluorouracil or carboplatin/paclitaxel for first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
Jimeno A; Machiels JP; Wirth L; Specenier P; Seiwert TY; Mardjuadi F; Wang X; Kapp AV; Royer-Joo S; Penuel E; McCall B; Pirzkall A; Clement PM
Cancer; 2016 Dec; 122(24):3803-3811. PubMed ID: 27525588
[TBL] [Abstract][Full Text] [Related]
38. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
Belani CP
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
[TBL] [Abstract][Full Text] [Related]
39. [Gemcitabine].
Takeda K
Nihon Rinsho; 2002 May; 60 Suppl 5():359-65. PubMed ID: 12101689
[No Abstract] [Full Text] [Related]
40. Docetaxel in head and neck cancer: a review.
Colevas AD; Posner MR
Am J Clin Oncol; 1998 Oct; 21(5):482-6. PubMed ID: 9781605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
